activL® Next Generation Instrumentation
K-Number: K231769 · 2023-07-13
ApplicantAesculap Implants Systems, LLC
Decision Date2023-07-13
Product CodeQLQ
Advisory CommitteeOR
DecisionSubstantially Equivalent
Device Summary
activL® Next Generation Instrumentation is a medical device manufactured by Aesculap Implants Systems, LLC. It received FDA 510(k) clearance on 2023-07-13 under approval number K231769. The device is classified under product code QLQ. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the activL® Next Generation Instrumentation?
activL® Next Generation Instrumentation is a medical device that received FDA 510(k) clearance on 2023-07-13. It is manufactured by Aesculap Implants Systems, LLC. The 510(k) number is K231769.
When was activL® Next Generation Instrumentation approved by the FDA?
activL® Next Generation Instrumentation received FDA 510(k) clearance on 2023-07-13, under approval number K231769.
What company makes activL® Next Generation Instrumentation?
activL® Next Generation Instrumentation is manufactured by Aesculap Implants Systems, LLC.
What is the FDA product code for activL® Next Generation Instrumentation?
The FDA product code for activL® Next Generation Instrumentation is QLQ.
Related Clinical Trials
Other Devices by Aesculap Implants Systems, LLC
Related Devices (Code: QLQ)
K211757Simplify DiscNuvasive, Inc.
K221848prodisc C SK, prodisc C Nova, and prodisc C Vivo InstrumentsCentinel Spine, LLC
K220861M6-C Artificial Cervical Disc Instruments ASSpinal Kinetics, LLC
K242869prodisc® L InstrumentsCentinel Spine, LLC
K241117M6-C Single Use, Disposable InstrumentationSpinal Kinetics / Orthofix / Seaspine
K250554prodisc® L InstrumentsCentinel Spine, LLC
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.